Chris Storgard is Chief Medical Officer at FATE THERAPEUTICS INC (FATE). They have made 1 open-market trade across 1 company since 2016, most recently 2016-11-23.
CIK 0001674703
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $200K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FATE | 37,593 | $79K |
Shares reported on the most recent Form 4, priced at the 2016-11-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FATE | BUY | 2016-11-23 | 2016-11-28 | $2.66 | $200K | -2.6% | -12.6% | +34.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.